Combining immunotherapy and targeted therapies in cancer treatment - PubMed (original) (raw)

• Decoding the epitranscriptome: a new frontier for cancer therapy and drug resistance.
  Tang L, Tian H, Min Q, You H, Yin M, Yang L, Zhao Y, Wu X, Li M, Du F, Chen Y, Deng S, Li X, Chen M, Gu L, Sun Y, Xiao Z, Li W, Shen J. Tang L, et al. Cell Commun Signal. 2024 Oct 21;22(1):513. doi: 10.1186/s12964-024-01854-w. Cell Commun Signal. 2024. PMID: 39434167 Free PMC article. Review.
• Case Report: Anlotinib combined with PD-1 inhibitor and sequential GA regimen or FOLFIRINOX Chemotherapy in treatment of KRAS G12V mutated pancreatic ductal adenocarcinoma with liver metastasis: A case and literature review.
  Wang Y, Wang B, Xiang L, Deng J, Xu B, He P, Pu W, Wang H, Fan Y, Chen H. Wang Y, et al. Front Immunol. 2022 Oct 13;13:1016647. doi: 10.3389/fimmu.2022.1016647. eCollection 2022. Front Immunol. 2022. PMID: 36311715 Free PMC article. Review.
• Classification of current anticancer immunotherapies.
  Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G. Galluzzi L, et al. Oncotarget. 2014 Dec 30;5(24):12472-508. doi: 10.18632/oncotarget.2998. Oncotarget. 2014. PMID: 25537519 Free PMC article. Review.
• Oncolytic Poxviruses.
  Chan WM, McFadden G. Chan WM, et al. Annu Rev Virol. 2014 Sep 1;1(1):119-141. doi: 10.1146/annurev-virology-031413-085442. Annu Rev Virol. 2014. PMID: 25839047 Free PMC article.
• Roles of NK Cell Receptors 2B4 (CD244), CS1 (CD319), and LLT1 (CLEC2D) in Cancer.
  Buller CW, Mathew PA, Mathew SO. Buller CW, et al. Cancers (Basel). 2020 Jul 1;12(7):1755. doi: 10.3390/cancers12071755. Cancers (Basel). 2020. PMID: 32630303 Free PMC article. Review.